Marktlink → Sectors → Science & Health
- Updated March 5, 2026
Where innovation meets patient impact
Science & Health is the highest-valued sector in multiple European markets. From biotech pipeline deals to medtech regulatory arbitrage, from healthcare PE roll-ups to pharmaceutical patent cliff acquisitions — buyers pay premiums for innovation, regulatory moats, and patient outcome data.
Explore Subsectors
Each subsector has its own valuation logic, buyer landscape, and growth dynamics.
Why Marktlink in “Science & Health”
IP & Regulatory Moats
Patents, CE marks, and clinical data create barriers to entry that buyers pay significant premiums for.
Resilient Demand
Healthcare spending grows regardless of economic cycles, providing revenue predictability that investors value.
What This Means for You
Interactive tools that give you immediate insights—or full reports in your personal portal.

